- Products (108)
- Resources (1270)
Spatial Imaging as a Tool for Discovery of New Candidates to Better Predict Response to Immunotherapies
Dr. David Rimm of Yale School of Medicine discusses multiplexing spatial imaging technologies and their development to improve response prediction for immunotherapy. This webinar was recorded at AACR 2022.
Hallmarks of Cancer: Sustaining Proliferative Signaling
Cancer cells stimulate their own growth, which means they become self-sufficient in growth signals, and no longer depend on external signals (like Epidermal Growth Factor EGF/ EGFR). Proliferation depends highly on these three important pathways: Akt, MAPK/Erk, and MTOR.
Cell Signaling Technology announces the issuance of a patent on novel "motif antibody" technology
U.S. Patent No. 6,441,140, directed to the production of a novel class of motif-specific, context-independent antibodies, highly useful for the identification of subclasses of protein kinase substrates.
Cell Signaling Technology Wins "Best Antibodies" and "Most Useful Website" at The Life Science Industry Awards
Cell Signaling Technology, a leading provider of antibodies, kits and services, announced today that it has won two Life Science Industry Awards® for "Best Antibodies" and "Most Useful Website."